Druggability of CRMP2 for neurodegenerative diseases

Pharmacology, Toxicology and Pharmaceutical Science

• Degenerative Disease 100%
• Malignant Neoplasm 50%
• Disease 50%
• Drug Discovery 50%
• Ubiquitin 50%
• Heterodimer 50%
• Chronic Pain 50%
• Tubulin 50%
• Bipolar Disorder 50%
• Ligand Gated Ion Channel 50%
• Phosphoprotein 50%
• Psychogenic Pain 50%
• Collapsin Response Mediator Protein 50%

Biochemistry, Genetics and Molecular Biology

• Posttranslational Modification 100%
• Small Molecule 50%
• Ubiquitin 50%
• Protein-Protein Interaction 50%
• Cell Division 50%
• Tubulin 50%
• Mediator 50%
• Semaphorin 50%
• Sumoylation 50%
• Phosphoprotein 50%
• Ligand-Gated Ion Channel 50%
• Multifunctional Protein 50%
• Voltage-Gated Channel 50%

Keyphrases

• Druggable Pockets 12%
• Discovery Function 12%